Asthma, COPD Disease Severity May Increase Risk of Developing Severe COVID-19
Disease severity of both chronic obstructive pulmonary disease (COPD) and asthma may increase the risk of the development of severe coronavirus disease 2019 (COVID-19).
COVID19
COVID-19 vs Non-COVID-19 ARDS: Comparing Characteristics, Outcomes
Although COVID-19 acute respiratory distress syndrome (ARDS) has some key differences from non-COVID-19 ARDS, these differences do not merit deviation from evidence-based ARDS management.
Oxford-AstraZeneca COVID-19 Vaccine: New Study Results, Variant Coverage Update, Where Do We Stand?
The Oxford-AstraZeneca COVID-19 vaccine, ChAdOx1, released 4 studies to analyze its efficacy in the prevention of mild, moderate, and severe COVID-19 infection; new studies also address rising concerns in the vaccine’s ability to protect against variants B.1.1.7 and B.1.351.
Upper Respiratory Tract COVID-19 Viral Load May Effectively Stratify Patients at High Risk for Severe Infection
Viral load of the COVID-19 in the upper respiratory tract may be an effective stratification method for severe outcomes, length of stay, and death.
Pfizer to Begin Clinical Trial of COVID-19 Vaccine in Pregnant Women
The first U.S. participants in a large-scale clinical trial to test the safety and efficacy of the Pfizer COVID-19 vaccine in pregnant women have received their shots.
Eye Abnormalities Identified in Severe COVID-19 Patients
Seven percent of patients with severe COVID-19 present with abnormal magnetic resonance imaging findings of the globe of the eye.
Many Cancer Survivors Have Conditions Linked to Risk for Severe COVID-19 Illness
More than half of cancer survivors have underlying medical conditions associated with severe COVID-19 illness.
COVID-19 Case Fatality Rate High in Patients with Long-Term Dialysis
Patients undergoing long-term dialysis who become infected with SARS-CoV-2 have a high COVID-19 case fatality rate.
Novel SARS-CoV-2 Variant From California Spreading Widely
Researchers describe the emergence of a novel variant of SARS-CoV-2, CAL.20C, which originated in Southern California.
Smokers Are at an Increased Risk of Developing Symptomatic COVID-19
Smokers are at an increased risk of developing symptomatic coronavirus 2019 (COVID-19).
-
Loading...
-
Loading...
Next post in Smoking
